Very elderly AF patients fare well on low-dose edoxaban
04 Nov 2020
byJairia Dela Cruz
Elderly patients with nonvalvular atrial fibrillation (AF) aged ≥80 years who cannot receive oral anticoagulants at recommended doses may do well instead on low-dose edoxaban, which prevents stroke without increasing the incidence of bleeding, according to the results of the phase III ELDERCARE-AF trial.
